SHANGHAI, Dec 2 (Reuters) - Sanofi plans to invest around 1 billion euros ($1.05 billion) to build a new insulin production ...

Sanofi SA will invest around 1 billion euros ($1.1 billion) to build a new insulin production base in Beijing, its biggest ...

Shortly after a similarly sized venture from Pfizer, French pharma juggernaut Sanofi has unveiled a major manufacturing ...

The French pharma firm is seeking to increase insulin production in Beijing as trade tensions between the EU and China simmer ...

Vice-Premier He Lifeng on Tuesday told Sanofi chairman Frédéric Oudéa that China will continue to improve its operating environment for businesses and welcome European firms in the country ...

The French drugmaker said that the investment of about 1 billion euros will enhance the production and manufacturing of ...

Sanofi unveiled a plan to build a $1 billion manufacturing site in Beijing while completing construction at a plant in ...

Sanofi just made its largest investment thus far in China. The company has committed just over $1 billion to build a new ...

Sanofi has announced plans to invest approximately €1bn to build a new insulin production base in China.

Sanofi is one of the world's top producers of insulin, and the China market for treatment of the illness is huge: Some 140 ...

France-based Sanofi S.A. (FR:SAN) is expanding its presence in China with an investment of €1 billion to build a new insulin manufacturing plant in Beijing. This represents Sanofi’s largest ...

Chinese authorities rolled out the red carpet for French pharmaceutical and healthcare giant Sanofi, which plans to invest ...